This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results. So, again, innovation is great.
Emphasizing innovative pathways for collaboration, including dynamic referral protocols, telemedicine, and shared decision-making, the proposed strategies aim to overcome structural and organizational barriers in healthcare.
Raj Makkar, MD, vice president of Cardiovascular Innovation and Intervention and the director of the Karsh Division of Interventional Cardiology in the Smidt Heart Institute at Cedars-Sinai, and his team of experts treat more than 10,000 patients every year. When might a minimally invasive procedure be the best approach?
milla1cf Thu, 05/16/2024 - 15:35 May 16, 2024 — A recent publication in the American Heart Association Circulation highlights a comprehensive investigation to assess the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia.
We are entering a new era of stroke care where data-driven insights guide every decision, said Bazan, senior author and the John Ochsner Professor of Cardiovascular Innovation at Ochsner Health. This allows for more refined, patient-centered care strategies that enhance both short-term recoveries and long-term quality of life.
The AccuCinch® System, utilized by Allegheny General Hospital, offers a breakthrough approach to treating heart failure by targeting the left ventricle.
This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients. This innovative approach not only addresses that need but also improves patient outcomes, ensuring a better quality of life for those diagnosed with A-Fib.
Allegheny Health Network (AHN) implants innovative device to manage central sleep apnea in heart failure patients, reducing mortality rise and improving quality of life.
Access to Cutting-Edge Techniques Many fellowships expose participants to the latest technologies and innovations in their field. These programs also prepare fellows for leadership roles, equipping them to drive change and innovation in their respective fields. When to Pursue a Fellowship? Here are some scenarios to consider: 1.
This can lead to symptoms such as severe shortness of breath, swelling in the legs and abdomen and a significant reduction in quality of life. We have been eagerly anticipating the opportunity to bring this innovative technology to our community.
Food and Drug Administration’s (FDA) Breakthrough Devices Program , which provides patients with timely access to innovative medical devices. Moreover, ECGvision-TTR paves the way for personalized care plans, enhancing the quality of life for individuals at risk of or suffering from ATTR-CM.
Early diagnosis, adherence, and innovation offer hope for improved outcomes and quality of life. Panelists discuss how chronic obstructive pulmonary disease (COPD) management is evolving with personalized therapies, nonpharmacological care, and advanced treatments.
Edwards has a long history of leading innovation and pioneering new therapies to address the unmet needs of patients with structural heart disease,” said Daveen Chopra , Edwards’ corporate vice president, transcatheter mitral and tricuspid therapies. “The
This news comes after the Innovation Value Institute ( IVI ) at Maynooth University in the Republic of Ireland selected Seismofit as one of five top digital health solutions helping to drive a radical transformation in healthcare, according to a written statement released by the company about the presentation.
Although tools for the youngest heart patients are limited, the Ochsner Children’s Hospital team provides top-of-the-line care to bridge patients safely to transplant and a hope for a better quality of life. Yet, research and innovation in this field has not kept pace.
"The opportunity to treat the hearts of pediatric patients with our life-supporting technology is incredible and fills us with gratitude," saidSonya Bhavsar, PhD, Senior Director, R&D, ECP & Pediatrics Platform, Heart Recovery, Johnson & Johnson MedTech.
The field of electrophysiology (EP) has benefited from numerous seminal innovations and discoveries that have enabled clinicians to deliver therapies and interventions that save lives and promote quality of life.
The A-FLUX Reducer implant is placed in the coronary sinus, the largest vein in the heart, and is designed to provide more blood flow to the ischemic portion of the heart and improve patient symptoms and quality of life, according to a written statement issued by VahatiCor. VahatiCor, Inc.,
This is a leading event in the cardiovascular medicine calendar, which brings together specialists from around the world to discuss the latest advances, research results and clinical innovations in the field of cardiology. A summary of the poster session will be published on the Journal of the American College of Cardiology’s website.
“We are thrilled to have a new transcatheter valve option which allows patients to feel significantly better by alleviating symptoms such as shortness of breath and can help improve the patients’ quality of life.”
In addition, quality of life and venous functional assessments that were performed in the VIVID study – including Clinical-Etiology-Anatomy-Pathophysiology (CEAP), Venous Clinical Severity Score (VCSS), Villalta, EQ-5D-3L and VEINES scores – showed sustained improvements compared to baseline at 12 months. “Duo
This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients. This innovative approach not only addresses that need but also improves patient outcomes, ensuring a better quality of life for those diagnosed with A-Fib.
This comparison contributes to theoretical innovation and practical development in the field of health management, as well as improving patients' health outcomes and quality of life.MethodsThis study employed a quasi-experimental design.
Other rehabilitation strategies that enhance cognitive reserve and pharmacological interventions are discussed about improving the quality of life in survivors.
With this milestone, more patients now have access to a treatment option to help reduce their heart failure symptoms and improve their quality of life when medications alone are not enough.” The announcement noted that this procedure also marks the first Barostim implant for CVRx on the home front.
These cutting-edge modalities not only enhance diagnostic precision but also facilitate more targeted and effective treatment strategies, improving survival rates and quality of life for countless women worldwide.
These cutting-edge modalities not only enhance diagnostic precision but also facilitate more targeted and effective treatment strategies, improving survival rates and quality of life for countless women worldwide.
CH STRONG is a project to gather information about care and quality of life from adults living with CHD. CHSTRONG KIDS gathers information about healthcare use, education, social experiences, and quality of life from families of children with heart defects.
About the Carillon Mitral Contour System Many heart failure patients suffer from functional mitral regurgitation, which when left untreated, exacerbates their heart failure, further weakening the heart, degrading their quality of life, and reducing survival.
Faster Recovery: Patients undergoing micro neurosurgery often experience faster recovery times, less pain, and shorter hospital stays, which can improve their overall quality of life. Innovative Techniques: Micro neurosurgery is at the forefront of medical innovation.
Faster Recovery: Patients undergoing micro neurosurgery often experience faster recovery times, less pain, and shorter hospital stays, which can improve their overall quality of life. Innovative Techniques: Micro neurosurgery is at the forefront of medical innovation.
Despite significant advancements, further research is essential to fully understand the mechanisms, optimize treatments, and fully harness the regenerative capabilities of stem cells, paving the way for innovative treatments that offer renewed hope for stroke patients.
Among these innovations, minimally invasive cardiac surgery stands out as a game-changer, offering numerous benefits over traditional open-heart surgery. This reduced recovery period can lead to a higher quality of life and less disruption to the patient’s routine.
In this article, we will explore the top 10 trends shaping the future of cardiovascular medicine, highlighting the innovative technologies and approaches that are revolutionizing the field. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.
Cardiorenal and metabolic diseases represent a complex constellation of lifestyle factors and health conditions that significantly impact longevity and quality of life. In the United States alone, an estimated 47 million people are affected by cardiorenal metabolic-related risk factors and diseases.
Peerbridge Health continues to innovate by compounding clinical utility in one simple device," said Andrea Natale, M.D., FACC, FHRS, FHSC , Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. David's Medical Center.
With this milestone, more patients now have access to a treatment option to help reduce their heart failure symptoms and improve their quality of life when medications alone are not enough.” The announcement noted that this procedure also marks the first Barostim implant for CVRx on the home front.
Hence, to reduce the risk of CVDs, regular diagnosis using advanced tools like the , Wellnest 12L ECG Machine and modern therapies such as Renal Denervation for treatment is needed to improve the health and quality of life of individuals with resistant blood pressure.
Third and perhaps most important, being able to use what I have learned here in US to make a very small dent to improve the quality of life for communities in low-middle income countries. Is this really what I want in life? Those are some of the biggest rewards I’ve had thus far in my academic career.
Patients with heart failure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden. Through a new four-year, $7.8 million Department of Defense grant awarded to the Georgia Institute of Technology (Georgia Tech), Yaxin Wang, PhD (seated left), O.H.
Background and purpose:The aim of this study is to assess the impacts of digital health interventions on quality of life and mental status in stroke patients. Stroke, Volume 56, Issue Suppl_1 , Page ANS5-ANS5, February 1, 2025. A total of 17 studies involving 1437 participants were included.
Participants also saw a significant improvement in quality of life and reduced healthcare utilizations in terms of cardiovascular hospitalizations, cardioversion, and antiarrhythmic drug use. Summary findings follow, as presented in a written statement from HRS after the presentation. All patients in the study achieved acute success.
25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content